Collagen fiber alignment

Collagen fiber alignment refers to the organized spatial arrangement of collagen fibrils within the extracellular matrix (ECM), a process critical for tissue architecture and mechanical properties (Source: PubMed PMID: 21903678). In healthy tissues, alignment is regulated to provide tensile strength, but in pathological states like cancer, collagen fibers often become linearized and bundled, creating 'highways' that facilitate tumor cell migration and metastasis (Source: PubMed PMID: 16854227). This phenomenon, known as Tumor-Associated Collagen Signatures (TACS), is a significant prognostic indicator in various malignancies. In fibrotic diseases, excessive alignment and cross-linking lead to increased tissue stiffness, which further drives disease progression through mechanotransduction pathways (Source: PubMed PMID: 23527577). While not a discrete molecular receptor, collagen alignment is a key therapeutic focus, with drugs like lysyl oxidase (LOX) inhibitors (e.g., PXS-5505) aiming to prevent the cross-linking that stabilizes these aligned structures. Modulating this alignment represents a strategy to normalize the microenvironment and improve the delivery and efficacy of other therapeutic agents (Source: PubMed PMID: 30215136).

Other names

Collagen organizationCollagen orientationTumor-associated collagen signaturesTACSCollagen anisotropyExtracellular matrix alignment

Inhibition of lysyl oxidase (LOX) and lysyl oxidase-like (LOXL) enzymes to prevent covalent cross-linking of collagen fibrils, modulation of TGF-beta signaling to reduce myofibroblast-mediated fiber tension, and enzymatic degradation of collagen via collagenases.